Whole Blood Transcriptome Analysis in Bipolar Disorder Reveals Strong Lithium Effect

Catharine E. Krebs,Anil P. S. Ori,Annabel Vreeker,Timothy Wu,Rita M. Cantor,Marco P. M. Boks,Rene S. Kahn,Loes M. Olde Loohuis,Roel A. Ophoff

DOI: https://doi.org/10.1017/s0033291719002745

IF: 10.592

2019-01-01

Psychological Medicine

Abstract:Bipolar disorder (BD) is a highly heritable mood disorder with complex genetic architecture and poorly understood etiology. We performed a whole blood transcriptome analysis in a BD case-control sample (Nsubjects = 480) by RNA sequencing. While we observed widespread differential gene expression patterns between affected and unaffected individuals, these effects were largely linked to lithium treatment at the time of blood draw (FDR < 0.05, Ngenes = 976) rather than BD diagnosis itself (FDR < 0.05, Ngenes = 6). These lithium-associated genes were enriched for cell signaling and immune response functional annotations, among others, and were associated with neutrophil cell-type proportions, which were elevated in lithium users. Neither genes with altered expression in cases nor in lithium users were enriched for BD, schizophrenia, and depression genetic risk based on information from genome-wide association studies, nor was gene expression associated with polygenic risk scores for BD. Our findings suggest that BD is associated with minimal changes in whole blood gene expression independent of medication use but underline the importance of accounting for medication use and cell type heterogeneity in psychiatric transcriptomic studies. The results of our study add to mounting evidence of lithium's cell signaling and immune-related mechanisms.